about
Overexpression of CD99 Increases the Migration and Invasiveness of Human Malignant Glioma CellsCD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesisCD99 is a novel prognostic stromal marker in non-small cell lung cancer.Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study.CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.Inactivation of X-linked tumor suppressor genes in human cancer.CD99 is essential for leukocyte diapedesis in vivo.Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model.The importance of Src signaling in sarcoma.The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell linesDiagnostic and prognostic sarcoma signatures.CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas.CD99 isoforms regulate CD1a expression in human monocyte-derived DCs through ATF-2/CREB-1 phosphorylation.CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.Cancer-associated mutations in the canonical cleavage site do not influence CD99 shedding by the metalloprotease meprin β but alter cell migration in vitro.Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.Expression of caveolin-1 in the early phase of beta-TCP implanted in dog mandible.CD99 at the crossroads of physiology and pathology.CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of β1 Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway.Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms.CD99 refers to the activity of inflammatory bowel disease.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.
P2860
Q24610083-B83342D6-4C6C-42D7-9D8E-2621A3509C96Q24642797-60C61D69-6B7C-4249-A1B4-FCB2A973A2CFQ34258877-1A4A52F1-2BD7-4A98-89D0-345581E98E40Q34614301-E76E7520-7EA9-4681-81BC-6F6290F17829Q34629236-25F17DCD-BB52-4D7D-8E48-744098BCCE1EQ35007531-CD3C1391-8DA2-46CA-9DBB-BE6963EB56C8Q35206452-0140505A-AC3E-4DD1-A8BF-BD83831348AAQ35628671-5BB33020-A8CD-4ECB-AD53-47A2EDCF13DCQ35678071-68E8DC0D-C6F0-4A24-BA26-8F239D30139FQ35802929-8A8FFAB8-B7B0-4D01-A83C-1B4F812BD4FAQ36672392-A8BFE2B1-310D-429A-AA14-F1BC8EAE2A21Q37335373-3126EDB6-43BA-4B8F-A448-85AB93401FC4Q37694869-C5B6EF9E-700F-4FA8-B1FA-FB170D2D6963Q38298890-699E65EF-D51A-41DF-8B09-C903ACDD8E1AQ38553340-91BA86C3-482B-4F8C-AE11-737E4BC3B630Q38777086-E7453B2A-CDA9-407D-88A2-764D5B2AC959Q38998414-86E32866-CAB2-4FE6-BB6F-98550F8E726AQ39156193-8ABAB52F-5998-4179-AD32-D71656BC32B9Q41550296-20CEF1F7-D5A7-44E8-8FB4-816ACE188D93Q42314424-35E8DC97-E422-408E-B56E-D0DFB7C03B3FQ46461150-2E7B2B98-FD68-45CB-A4A5-C8835F987F21Q47203268-7C676BDD-E452-44AC-845B-278D3ACF47CFQ49308020-1A662E5B-0018-4077-A9AC-AE20A8CE57CDQ50197867-A2E216FD-3F2B-4603-8C8E-16B59B30A839Q51315227-BE586F6B-6AD9-4499-BBF3-E8065613F6C6Q52658031-9010C35F-EE15-45A8-89B2-EF015129FBB0
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
CD99 acts as an oncosuppressor in osteosarcoma
@ast
CD99 acts as an oncosuppressor in osteosarcoma
@en
CD99 acts as an oncosuppressor in osteosarcoma
@nl
type
label
CD99 acts as an oncosuppressor in osteosarcoma
@ast
CD99 acts as an oncosuppressor in osteosarcoma
@en
CD99 acts as an oncosuppressor in osteosarcoma
@nl
prefLabel
CD99 acts as an oncosuppressor in osteosarcoma
@ast
CD99 acts as an oncosuppressor in osteosarcoma
@en
CD99 acts as an oncosuppressor in osteosarcoma
@nl
P2093
P2860
P50
P356
P1476
CD99 acts as an oncosuppressor in osteosarcoma
@en
P2093
Alain Bernard
Ghislaine Bernard
Lorena Landuzzi
Maria Cristina Manara
Marika Sciandra
Monia Zuntini
Stefania Benini
P2860
P304
P356
10.1091/MBC.E05-10-0971
P50
P577
2006-01-18T00:00:00Z